Author: Tartarone, Alfredo; Lerose, Rosa
Title: COVID-19 and cancer care: what do international guidelines say? Cord-id: egsha2j7 Document date: 2020_8_7
ID: egsha2j7
Snippet: Cancer patients are at particular risk from COVID-19 since they usually present multiple risk factors for this infection such as older age, immunosuppressed state, comorbidities (e.g., chronic lung disease, diabetes, cardiovascular diseases), need of frequent hospital admissions and visits. Therefore, in the COVID era, oncologists should carefully weigh risks/benefits when planning cancer therapies and follow-up appointments. Recently, several scientific associations developed specific guideline
Document: Cancer patients are at particular risk from COVID-19 since they usually present multiple risk factors for this infection such as older age, immunosuppressed state, comorbidities (e.g., chronic lung disease, diabetes, cardiovascular diseases), need of frequent hospital admissions and visits. Therefore, in the COVID era, oncologists should carefully weigh risks/benefits when planning cancer therapies and follow-up appointments. Recently, several scientific associations developed specific guidelines or recommendations to help physicians in their clinical practice. This review focuses on main available guidelines/recommendations regarding the cancer patient management during the COVID-19 pandemic.
Search related documents:
Co phrase search for related documents- active cancer and low medium: 1
- active cancer therapy and adjuvant therapy: 1
- active cancer treatment and adjuvant therapy: 1
- active treatment and adjuvant therapy: 1, 2, 3, 4, 5
- active treatment and low priority: 1, 2
Co phrase search for related documents, hyperlinks ordered by date